Skip to main content
ONC logo

ONC · BeOne Medicines Ltd. · Analyst Estimates

Track ONC — free
$365.94 +0.67 (+0.18%) At close · Sep 30
Market Cap
$40.82B
Shares
113.12M
Volume · Sep 30 328.88K Avg daily vol (3M) 388.06K

Analyst Estimates

Compare analyst forecasts for BeOne Medicines Ltd. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-30 20:03 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
6.52
7.60227
8.82913
—
7.59764
6.43545
7.60227
6.59048
— — — —
EPS
analysts
Publication date not stated
— — —
16
— — — —
2
1
12
13
Revenue
USD
Publication date not stated
6668608440
6769763590
7124810000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
31
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
6.39
10.31755
15.23596
—
10.2839
9.62955
10.31755
9.7154
— — — —
EPS
analysts
Publication date not stated
— — —
17
— — — —
6
6
10
8
Revenue
USD
Publication date not stated
6834000000
7756097770
8473053000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
33
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.56455
1.81932
2.11
—
1.81932
1.70009
1.81932
1.72554
— — — —
EPS
analysts
Publication date not stated
— — —
11
— — — —
3
3
7
7
Revenue
USD
Publication date not stated
1720114000
1752386460
1773000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.87
1.53719
1.91
—
1.53038
1.32802
1.53038
1.43681
— — — —
EPS
analysts
Publication date not stated
— — —
11
— — — —
3
3
7
7
Revenue
USD
Publication date not stated
1728111000
1783973940
1837000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —
Key facts CIK 1651308 CUSIP 07725L102 13F (30d) 10 filings 8 filers Visit website Investor relations